Literature DB >> 26018738

Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly.

Iris Crespo1, Alicia Santos1, Elena Valassi1, Patricia Pires2, Susan M Webb1, Eugenia Resmini3.   

Abstract

Evaluation of cognitive function in acromegaly has revealed contradictory findings; some studies report normal cognition in patients with long-term cured acromegaly, while others show attention and memory deficits. Moreover, the presence of affective disorders in these patients is common. Our aim was to evaluate memory and decision making in acromegalic patients and explore their relationship with affective disorders like anxiety and depressive symptoms. Thirty-one patients with acromegaly (mean age 49.5 ± 8.5 years, 14 females and 17 males) and thirty-one healthy controls participated in this study. The Iowa Gambling Task (IGT), Rey Auditory Verbal Learning Test, State-Trait Anxiety Inventory, and Beck Depression Inventory-II (BDI-II) were used to evaluate decision making, verbal memory, anxiety, and depressive symptoms, respectively. Acromegalic patients showed impairments in delayed verbal memory (p < 0.05) and more anxiety and depressive symptoms (p < 0.05) than controls. In the IGT, acromegalic patients presented an altered decision-making strategy compared to controls, choosing a lower number of the safer cards (p < 0.05) and higher number of the riskier cards (p < 0.05). Moreover, multiple correlations between anxiety and depressive symptoms and performance in memory and decision making were found. Impaired delayed memory and decision making observed in acromegalic patients are related to anxiety and depressive symptoms. Providing emotional support to the patients could improve their cognitive function. A key clinical application of this research is the finding that depressive symptoms and anxiety are essentially modifiable factors.

Entities:  

Keywords:  Acromegaly; Anxiety; Cognitive function; Decision making; Depression; Memory

Mesh:

Year:  2015        PMID: 26018738     DOI: 10.1007/s12020-015-0634-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

1.  Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex.

Authors:  Pauline Brummelman; Margriet G A Sattler; Linda C Meiners; Martin F Elderson; Robin P F Dullaart; Gerrit van den Berg; Janneke Koerts; Oliver Tucha; Bruce H R Wolffenbuttel; Alfonsus C M van den Bergh; André P van Beek
Journal:  Eur J Endocrinol       Date:  2011-11-09       Impact factor: 6.664

Review 2.  On the relationship between emotion and cognition.

Authors:  Luiz Pessoa
Journal:  Nat Rev Neurosci       Date:  2008-02       Impact factor: 34.870

Review 3.  Construct validity of the Iowa Gambling Task.

Authors:  Melissa T Buelow; Julie A Suhr
Journal:  Neuropsychol Rev       Date:  2009-02-05       Impact factor: 7.444

4.  The role of source memory in gambling task decision making.

Authors:  Paul Whitney; John M Hinson
Journal:  J Clin Exp Neuropsychol       Date:  2012-05-04       Impact factor: 2.475

Review 5.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

6.  Anxiety impairs decision-making: psychophysiological evidence from an Iowa Gambling Task.

Authors:  Andrei C Miu; Renata M Heilman; Daniel Houser
Journal:  Biol Psychol       Date:  2007-12-07       Impact factor: 3.251

7.  Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition.

Authors:  Pauline Brummelman; Janneke Koerts; Robin P F Dullaart; Gerrit van den Berg; Oliver Tucha; Bruce H R Wolffenbuttel; André P van Beek
Journal:  Eur J Clin Invest       Date:  2012-10-20       Impact factor: 4.686

8.  The impact of stress on financial decision-making varies as a function of depression and anxiety symptoms.

Authors:  Oliver J Robinson; Rebecca L Bond; Jonathan P Roiser
Journal:  PeerJ       Date:  2015-02-12       Impact factor: 2.984

9.  Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.

Authors:  Victor Jacobus Geraedts; Christina Dimopoulou; Matthias Auer; Jochen Schopohl; Günter Karl Stalla; Caroline Sievers
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-06       Impact factor: 5.555

10.  Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegaly.

Authors:  Juan Francisco Martín-Rodríguez; Ainara Madrazo-Atutxa; Eva Venegas-Moreno; Pedro Benito-López; María Ángeles Gálvez; David A Cano; Francisco J Tinahones; Elena Torres-Vela; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more
  12 in total

1.  Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.

Authors:  Alberto M Pereira
Journal:  Endocrine       Date:  2015-09-08       Impact factor: 3.633

Review 2.  Update on quality of life in patients with acromegaly.

Authors:  Iris Crespo; Elena Valassi; Susan M Webb
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy.

Authors:  H Alibas; K Uluc; P Kahraman Koytak; M M Uygur; N Tuncer; T Tanridag; D Gogas Yavuz
Journal:  J Endocrinol Invest       Date:  2017-06-28       Impact factor: 4.256

4.  Evidence of dysexecutive syndrome in patients with acromegaly.

Authors:  Shaobo Shan; Lingling Fang; Jia Huang; Raymond C K Chan; Guijun Jia; Weiqing Wan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

5.  Stigma and unhealthy psychological characteristics in patients with acromegaly: A cross-sectional study and identification of the associated factors.

Authors:  Yanqing Li; Xiaomei Zhang; Jiajia Zhang; Dandan Zhang; Ya Wang; Yingqian Zhu; Xiuqun Xu
Journal:  Acta Neurochir (Wien)       Date:  2022-05-21       Impact factor: 2.816

6.  General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers.

Authors:  Ozlem Haliloglu; Burak Dogangun; Bahar Ozcabi; Hanife Ugur Kural; Fatma Ela Keskin; Hande Mefkure Ozkaya; Fatma Colkesen Pamukcu; Elif Bektas; Burc Cagri Poyraz; Hakan Buber; Olcay Evliyaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 7.  Cognitive-behavioral therapy improves the quality of life of patients with acromegaly.

Authors:  Lia Silvia Kunzler; Luciana Ansaneli Naves; Luiz Augusto Casulari
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

8.  The Role of Growth Hormone in Depression: A Human Model.

Authors:  Mubarak Algahtany; Shubham Sharma; Khalid Fahoum; Rowan Jing; Stanley Zhang; Kalman Kovacs; Fabio Rotondo; John Lee; Irene Vanek; Michael D Cusimano
Journal:  Front Neurosci       Date:  2021-06-24       Impact factor: 4.677

9.  Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing's disease.

Authors:  Emre Durcan; Senol Turan; Serdar Sahin; Cem Sulu; Sabriye Sibel Taze; Yasin Kavla; Hande Mefkure Ozkaya; Pinar Kadioglu
Journal:  Pituitary       Date:  2021-03-05       Impact factor: 4.107

10.  The Structural Connectivity Pattern of the Default Mode Network and Its Association with Memory and Anxiety.

Authors:  Yan Tao; Bing Liu; Xiaolong Zhang; Jin Li; Wen Qin; Chunshui Yu; Tianzi Jiang
Journal:  Front Neuroanat       Date:  2015-11-26       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.